Clinical trial Recruiting at 1 site Observational Ages 40 to 85

Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease for adults with PD

Official title: Validity and Reliability of the Turkish Version of the Cognitive Self-Efficacy Questionnaire in Individuals With Parkinson's Disease

Run by Acibadem University · NCT07488377 · Data updated 2026-11-12

This study tests whether the Turkish version of the Cognitive Self-Efficacy Questionnaire is reliable and valid for people with Parkinson's disease.

More Parkinson Disease trials

Quick facts

Study typeObservational
Ages40 Years to 85 Years
SexAll
Enrollment100 (estimated)
SponsorAcibadem University
Academic / other
Locations1 site (Istanbul, Turkey)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJanuary 1, 2027
Study endsApril 1, 2027
Registry record updatedJuly 15, 2026
Trial IDNCT07488377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–85 with Parkinson's disease, Hoehn and Yahr 1–3, MMSE ≥24, able to consent and complete assessments, attending Istanbul Cerrahpaşa Neurology/Movement Disorders Clinic.

Probably not a fit

Patients with advanced dementia, major depression or psychotic disorders, severe sensory impairments, or inability to complete assessments may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study assesses the reliability and validity of the Turkish Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease. Participants are adults aged 40–85 with PD in Hoehn and Yahr stages 1–3, who can complete assessments and consent. The study uses the Turkish questionnaire as the sole instrument to measure cognitive self-efficacy and evaluate its psychometric properties. Participants are recruited from the Movement Disorders Outpatient Clinic at Istanbul Cerrahpaşa and must meet MMSE and other inclusion criteria. No intervention beyond questionnaire completion is described.

Why it matters

Potential benefit: If successful, the Turkish questionnaire could provide a validated tool for measuring cognitive self-efficacy in Turkish-speaking PD patients.

How similar studies have gone: Previous work in other languages supports the use of this type of instrument, but validation in Turkish for PD is being established by this study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Parkinson's disease
* Hoehn and Yahr stage 1-3
* Age 40 to 85 years
* Mini-Mental State Examination (MMSE) score ≥24
* Able to communicate and complete study assessments
* Attending the Movement Disorders Outpatient Clinic, Department of Neurology, Istanbul Cerrahpaşa Faculty of Medicine Hospital
* Able and willing to provide written informed consent

Exclusion Criteria:

* Major depressive disorder or psychotic disorder
* Advanced dementia
* Severe visual impairment that may interfere with study assessments
* Severe hearing impairment that may interfere with study assessments
* Inability to cooperate with the physiotherapist
* Inability to complete the study assessments

Where it's running

  • Acibadem University
    Istanbul, Turkey, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.